|

[177Lu]Lu-XT771 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Beijing Tiantan Hospital1

Indications

  • Recurrent Glioblastoma (WHO-Grade IV Glioma)1
  • Recurrent Glioblastoma, IDH-Wildtype1
  • Glioblastoma (GBM)1
  • Recurrent Glioblastoma1
  • Cancer1

Other1 trial

Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.